凝血因子Ⅴ(F5)重組蛋白
Recombinant Coagulation Factor V (F5)
FV; FVL; PCCF; Proaccelerin; Labile Factor; Factor V Leiden; Accelerator Globulin; Activated protein C cofactor; Proaccelerin, labile factor
- 編號RPA675Hu03
 - 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
 - 來源原核表達
 - 宿主E.coli
 - 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
 - 亞細胞定位分泌
 - 預(yù)測分子量35.2kDa
 - 實際分子量34kDa(差異分析請參閱說明書)
 - 片段與標(biāo)簽Arg1908~Val2203 with N-terminal His Tag
 - 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
 - 性狀凍干粉
 - 純度> 95%
 - 等電點9.5
 - 應(yīng)用Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白,請參見活性蛋白。 - 下載英文說明書 中文說明書
 - 規(guī)格10μg50μg200μg1mg5mg
 - 價格¥ 1114¥ 2784¥ 5568¥ 16704¥ 41760
 - 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
 
序列

用法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) | 
| RPA675Hu01 | 凝血因子Ⅴ(F5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA675Hu02 | 凝血因子Ⅴ(F5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| RPA675Hu03 | 凝血因子Ⅴ(F5)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| PAA675Hu01 | 凝血因子Ⅴ(F5)多克隆抗體 | WB,IHC,ICC/IF | 
| PAA675Hu03 | 凝血因子Ⅴ(F5)多克隆抗體 | WB; IHC; ICC; IP. | 
| PAA675Hu02 | 凝血因子Ⅴ(F5)多克隆抗體 | WB; IHC; ICC; IP. | 
| LAA675Hu81 | 凝血因子Ⅴ(F5)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. | 
| LAA675Hu71 | 凝血因子Ⅴ(F5)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. | 
| MAA675Hu22 | 凝血因子Ⅴ(F5)單克隆抗體 | WB; IHC; ICC; IP. | 
| SEA675Hu | 凝血因子Ⅴ(F5)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| LMA675Hu | 凝血因子Ⅴ(F5)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. | 
參考文獻
| 雜志 | 參考文獻 | 
| Biochem Biophys Res Commun | Thrombin generation in abdominal sepsis is Rho-kinase-dependent[PubMed: 25813486] | 
| Cell Transplantation | Evidence of a Pivotal Role for the Distal Part of the Complement Cascade in the Diurnal Release of Hematopoietic Stem Cells Into Peripheral Blood[Pubmed:26087465] | 
| Cardiovascular?Research | Loss of accelerates arterial thrombosis by increasing formation of neutrophil extracellular traps and plasma tissue factor activity[Pubmed:29444200] | 



